CVS stock profile - insider summary
- Name
- Date
- Title
- Total Bought
- Total Sold
- Updated
- IssuerCik
- SubKey
- netTransacted
-
VERRECCHIA ALFRED J2022/12/112832022-12-1100000648030000064803283
-
Havanec Laurie P.2022/12/10EVP and Chief People Officer93505-52332022-12-100000064803000006480388272
-
Havanec Laurie P.2022/12/09EVP and Chief People Officer93505-52332022-12-090000064803000006480388272
-
SGARRO DOUGLAS A2022/12/08EVP and CLO1657471-9701952022-12-0800000648030000064803687276
-
Havanec Laurie P.2022/12/07EVP and Chief People Officer93505-52332022-12-070000064803000006480388272
-
Havanec Laurie P.2022/12/06EVP and Chief People Officer93505-52332022-12-060000064803000006480388272
-
Havanec Laurie P.2022/12/05EVP and Chief People Officer93505-52332022-12-050000064803000006480388272
-
Havanec Laurie P.2022/12/04EVP and Chief People Officer93505-52332022-12-040000064803000006480388272
-
Havanec Laurie P.2022/12/03EVP and Chief People Officer93505-52332022-12-030000064803000006480388272
-
Hourican Kevin2022/12/02EVP & President, CVS Pharmacy220326-141622022-12-0200000648030000064803206164
Related News

ExxonMobil (NYSE: XOM) Q1 2025 Earnings: A Strong Buy Amidst Challenges in the Energy Market
TradingNEWS Archive
07.05.25

Is NYSE:LLY Stock a Buy at $700? Analysts See Massive Potential with a Price Target of $1,074
TradingNEWS Archive
07.05.25

Is NASDAQ:AMZN Stock Ready for Explosive Growth? Here’s Why It’s a Must-Buy at $145
TradingNEWS Archive
07.05.25